COT statement on surveillance for the mycotoxin moniliformin

The COT considered data on the toxicology of moniliformin and the results of a survey for moniliformin in commercial maize and in retail maize-based foods.

It welcomed the new data and was reassured by the low exposure indicated by the surveillance data. However, the available toxicological information on moniliformin did not allow it to make a full assessment of the possible risks to humans. It therefore made recommendations for further toxicity studies.